DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Kitazawa T, Esaki K, Tachibana T. , et al.
Factor VIIIa-mimetic cofactor activity of a bispecific antibody to factors IX/IXa and X/Xa, emicizumab, depends on its ability to bridge the antigens.
ThrombHaemost 2017;
117 (07) 1348-1357
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.